University of Greenwich, London UK (2014) HK1129206 (A1): New medical use of triazine derivatives. .

Full text not available from this repository.

Abstract

Compounds of formula (I) especially where R1 is an optionally substituted alkyl, aralkyl or heterocyclyl-alkyl group, are shown to have activity as sodium channel blockers or as antifolates. Some novel compounds where R1 is an aralkyl or heterocyclyl-alkyl are disclosed.

Item Type:	Patent
Uncontrolled Keywords:	Triazines, Sodium channel blockers, Neurodegeneration
Faculty / School / Research Centre / Research Group:	Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Last Modified:	09 Oct 2021 04:46
URI:	http://gala.gre.ac.uk/id/eprint/12487

Actions (login required)

View Item